Lung cancer News

February 4, 2015February 4, 2015

Molecularly-Guided Therapy Cost Effective for NSCLC

Lung cancer News, News

Some patients with non-small cell lung cancer (NSCLC) and the clinicians who treat them may be inclined to start a chemotherapy regimen immediately upon diagnosis. However, guidelines recommend patients undergo ... Read more

January 21, 2015

Moffitt Develops PLA to Diagnose Lung Cancer

Lung cancer News, News

Moffitt Cancer Center researchers are working to aid patients with lung cancer by developing new strategies for screening and generating prognoses. Published in the newest issue of Science Signaling, an ... Read more

January 14, 2015January 20, 2015

Lung Cancer Scans Together With Head And Neck Cancer Screening May Improve Survival

Lung cancer News, News

A recent analysis by University of Pittsburgh Cancer Institute researchers has found that in addition to recommended lung screenings, adding head and neck cancer screenings can be beneficial for early ... Read more

December 11, 2014December 11, 2014

BeyondSpring Initiating Phase 3 Trial of Plinabulin for NSCLC in Q1 of 2015

Lung cancer News, News

BeyondSpring Pharmaceuticals will bring its lead compound, Plinabulin, to phase 3 clinical trials for the treatment of non-small cell lung cancer (NSCLC) in the first quarter of 2015. The news ... Read more

November 7, 2014November 18, 2014

Personalized Medicine for NSCLC Patients Successful

Lung cancer News, News

Personalized medicine for lung cancer patients is on the horizon as a result of recommendations issued by the International Association for the Study of Lung Cancer (IASLC). As described in ... Read more

November 3, 2014November 18, 2014

The Lung Cancer Test is Now Marketed by Global Cancer Diagnostics

Lung cancer News

Imagine spending only $99 to receive a suggestive diagnosis that could change your life. Arizona-based Global Cancer Diagnostics Inc. is now offering a blood test that allows for early detection ... Read more

October 31, 2014November 18, 2014

Bristol-Myers Squibb NSCLC Treatment Results Announced

Lung cancer News, News

Results from Bristol-Myers Squibb Company’s phase 2 clinical trial CheckMate -063 studying Opdivo (nivolumab) in patients with advanced squamous cell non-small cell lung cancer (NSCLC) indicated a 15% objective response ... Read more

September 30, 2014September 30, 2014

Non-small Cell Lung Cancer Drug Demcizumab From OncoMed Shows Safety, Anti-Tumor Activity in Phase 1b Trials

Lung cancer News, News

OncoMed Pharmaceuticals Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), has presented safety and efficacy data from a Phase 1b clinical trial assessing the efficacy ... Read more

September 29, 2014September 29, 2014

NCI/FDA Lung Cancer Workshop Leads To LUNG-MAP And ALCHEMIST Clinical Trials

Lung cancer News, News

Two of the most innovative lung cancer focused clinical studies launched recently, the Lung Cancer Master Protocol (Lung-MAP) and the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST), ... Read more

September 25, 2014September 25, 2014

Small Cell Lung Cancer Features Novel Oncogenic RET Mutation, According To New Research

Lung cancer News, News

A team of scientists from Case Western University recently discovered a somatic mutation on oncogene RET in small cell lung cancer (SCLC) tumors that is responsible for tumor growth via activation of ... Read more